Eflornithine (DFMO; α-difluoromethylornithine; MDL-71782; RMI-71782; trade names: Vaniqa among others) is an approved medication used to treat African trypanosomiasis and excessive hair growth on the face in women. Specifically, it is used for the 2nd stage of sleeping sickness caused by T. b. gambiense and may be used in combination with nifurtimox.

纯度：≥98%

CAS：67037-37-0